UK biotech firm Epoch Biodesign closes $12 million funding round, including investment from Lululemon, to scale its enzymatic recycling technology
LONDON – UK‑based biotech startup Epoch Biodesign has raised $12 million in a strategic funding round that includes a new investment from Canadian athleticwear brand Lululemon.
Epoch said the capital would accelerate commercialisation of its recycled nylon 6,6 and scale production from a pilot facility to a larger demonstration site designed to validate commercial-scale output.
Already have an account? Log In




